176
Participants
Start Date
January 31, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Betaseron (Interferon beta-1b, BAY86-5046)
Telephone survey of all patients.
Philadelphia
Baltimore
Birmingham
San Francisco
Tucson
Chicago
Vancouver
London
Montreal
Montreal
Lead Sponsor
Bayer
INDUSTRY